Free Trial

Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 56

Apple Watch stock price forecast
January 1, 2024 7:55 AM ET

Is the Apple Watch ban the tipping point?

Jea Yu

Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the

NASDAQ:AAPLNASDAQ:MASINASDAQ:GOOGL
Read Is the Apple Watch ban the tipping point?
Microsoft stock price
December 29, 2023 7:32 AM ET

Microsoft is new cybersecurity titan, challenging big tech rivals

Kate Stalter

Microsoft is a key player in cybersecurity, competing with companies such as CrowdStrike and Amazon. Its annual cybersecurity business grew to $20 billion.

NASDAQ:MSFTNASDAQ:GOOGLNASDAQ:AMZN
Read Microsoft is new cybersecurity titan, challenging big tech rivals
Cruise Lines stocks
December 29, 2023 6:45 AM ET

Cruise lines navigate from worst to first in 2023 surge

Kate Stalter

The cruise industry has transformed itself, led by Royal Caribbean, Carnival and Norwegian. Companies focus on affordable pricing and higher profit margins.

NYSE:CCLNYSEARCA:XLYNYSE:NCLH
Read Cruise lines navigate from worst to first in 2023 surge
small cap stocks
December 29, 2023 6:41 AM ET

Small-cap surge: Outpacing large caps on hopes for '24 rate cuts

Kate Stalter

Small-cap stocks surged past large caps recently, fueled by lower interest rates and renewed economic confidence. Small growth and value are both rallying.

NYSE:MTHNASDAQ:SPSCNYSEARCA:SPY
Read Small-cap surge: Outpacing large caps on hopes for '24 rate cuts
Synopsys stock price outlook
December 29, 2023 6:40 AM ET

Synopsys stock: Unsung hero of the AI revolution

Kate Stalter

Synopsis, the leading provider of electronic design automation software, is up more than 60% in 2023 as customers AMD, Nvidia and Intel expand AI capabilities.

NASDAQ:SNPSNASDAQ:ALTRNASDAQ:ANSS
Read Synopsys stock: Unsung hero of the AI revolution
Apple stock price outlook
December 29, 2023 6:28 AM ET

Apple stock is institutional favorite, but is it overvalued?

Kate Stalter

Despite a strong performance in 2023, the company's revenue and earnings growth are slowing. Should investors keep holding, or is the stock overvalued?

NASDAQ:AAPLNASDAQ:GOOGLNASDAQ:AMZN
Read Apple stock is institutional favorite, but is it overvalued?
Insider stocks
December 28, 2023 8:35 AM ET

Insiders bet big on these turnaround stocks

Thomas Hughes

Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead.

NASDAQ:DCTHNYSE:BALYNYSE:PRGO
Read Insiders bet big on these turnaround stocks
Rivian Stock price outlook
December 28, 2023 7:45 AM ET

Rivian is all set to start 2024 with a bang

Sam Quirke

Rivian shares are up 53% since the middle of November, more than twice that of Tesla's 21% return and almost four times that of the DRIV ETF's 14% return.

NASDAQ:AMZNNASDAQ:TSLANASDAQ:RIVN
Read Rivian is all set to start 2024 with a bang
Dogs of the Dow with inscription on the sheet.
December 28, 2023 7:38 AM ET

If you buy the dogs, should you sell these Dow leaders?

Thomas Hughes

The Dogs of the Dow is a great strategy for value and income, but letting the winners run is equally essential to maximize returns.

NYSE:CRMNASDAQ:INTCNASDAQ:MSFT
Read If you buy the dogs, should you sell these Dow leaders?
Ray Dalio stocks
December 28, 2023 6:52 AM ET

Ray Dalio keeps adding to this ETF, what's he thinking?

Gabriel Osorio-Mazilli

Ray Dalio is going to be happy with his newest purchases into Asian stocks, there are two in particular that could bring in a good bulk of returns to this play

OTCMKTS:SSNLFOTCMKTS:TCEHYNASDAQ:PDD
Read Ray Dalio keeps adding to this ETF, what's he thinking?
2 Tech stocks getting bullish upgrades ahead of Q1
December 28, 2023 6:45 AM ET

2 Tech stocks getting bullish upgrades ahead of Q1

Sam Quirke

Stocks the analysts are upgrading tend to outperform their peers. With that in mind, here are two tech stocks that analysts have just upgraded ahead of 2024. 

NYSE:CRMNASDAQ:FROG
Read 2 Tech stocks getting bullish upgrades ahead of Q1
Q1 earnings
December 28, 2023 5:00 AM ET

What to expect from the Q1 earnings reporting cycle

Thomas Hughes

The FQ4 earnings reporting season starts soon and will determine the S&P 500's direction in 2024. The risk is that gains will be capped but there is hope.

NYSEARCA:XLUNYSEARCA:XLKNYSEARCA:XLC
Read What to expect from the Q1 earnings reporting cycle
SoftBank's billion-dollar bet pays off
December 27, 2023 12:19 PM ET

SoftBank's billion-dollar bet pays off

Jeffrey Neal Johnson

SoftBank achieves a substantial financial boost from a telecom merger presenting a mixed risk-reward scenario for potential investors.

OTCMKTS:SFTBYNASDAQ:TMUSNYSE:WE
Read SoftBank's billion-dollar bet pays off
Dogs of the Dow
December 27, 2023 9:42 AM ET

Are high-yield Dow Dogs a good buy for 2024? 

Thomas Hughes

These Dow Dogs are also the highest-yielding names on the Dow list. All are trading near recent bottoms and pay above-average yields with an average above 6%.

NYSE:VZNYSE:MMMNASDAQ:WBA
Read Are high-yield Dow Dogs a good buy for 2024? 
Synopsys stock price
December 27, 2023 9:23 AM ET

Synopsys offers to acquire Ansys, sparks stock surge

Kate Stalter

Ansys stock rose 18% on Synopsys acquisition news. Fellow engineering software maker Altair also rose on speculation it may be an acquisition target.

NASDAQ:ANSSNASDAQ:ALTRNASDAQ:ADSK
Read Synopsys offers to acquire Ansys, sparks stock surge
Bullish stocks outlook
December 27, 2023 8:35 AM ET

The most upgraded stocks from 2023: buy, sell or hold?

Thomas Hughes

The most upgraded stocks in 2023 had solid years with at least a 55% upside; most increased more than 100%, and another year of gains is forecast for 2024.

NYSEARCA:SPYNASDAQ:MSFTNASDAQ:NVDA
Read The most upgraded stocks from 2023: buy, sell or hold?
Occidental Petroleum stock
December 27, 2023 8:35 AM ET

Buffett keeps buying Occidental Petroleum, should you? 

Thomas Hughes

Berkshire Hathaway buys more OXY and sends the shares moving up from the bottom of a range; higher prices are ahead and may be reached soon.

NYSE:OXY
Read Buffett keeps buying Occidental Petroleum, should you? 
Nio stock price
December 27, 2023 7:04 AM ET

The truth behind NIO's 60.0% upside

Gabriel Osorio-Mazilli

NIO stock is on the rise, and its most recent quarter points to some of the reasons why traders are buying record volumes of call options, going up?

NYSE:GSNYSE:NIOOTCMKTS:BYDDY
Read The truth behind NIO's 60.0% upside
Liquidia: Court victory the awakening of an industry giant?
December 27, 2023 6:57 AM ET

Liquidia: Court victory the awakening of an industry giant?

Ryan Hasson

Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.

NASDAQ:UTHRNASDAQ:LQDA
Read Liquidia: Court victory the awakening of an industry giant?
T-mobile stock price
December 27, 2023 6:55 AM ET

T-Mobile is suddenly the industry gem with analyst target boosts

Gabriel Osorio-Mazilli

T-Mobile is delivering everything investors would hope for, upside and safety, growth projections above competitors, and even a price target boost!

NYSE:WFCNYSE:UBSNYSE:UBER
Read T-Mobile is suddenly the industry gem with analyst target boosts
Cleveland-Cliffs stock price
December 27, 2023 5:30 AM ET

Could Cleveland-Cliffs be the next steel company to be acquired?

Jea Yu

On Dec. 18, 2023, Iconic steel producer United States Steel Inc. announced it had agreed to be acquired by Japan’s largest steel maker, Cleveland-Cliffs next ?

NYSE:CLFOTCMKTS:NPSCYNYSE:NUE
Read Could Cleveland-Cliffs be the next steel company to be acquired?
XPO stock price
December 27, 2023 5:12 AM ET

Markets love XPO, your stuff still needs to get where it's going

Gabriel Osorio-Mazilli

The transport industry keeps adding jobs, and a 2024 filled with potential rate cuts can spur further activity into these stocks, but only one can be a winner

NYSE:XPONASDAQ:JBHTNASDAQ:SAIA
Read Markets love XPO, your stuff still needs to get where it's going
CRISPR Therapeutics stock price
December 27, 2023 5:00 AM ET

CRISPR Therapeutics sets sights on gene-editing cures for disease

Jea Yu

On Dec. 8, 2023, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced the U.S. FDA approved its sickle-cell disease (SCD) treatment, Casgevy, for

NASDAQ:CRSPNASDAQ:VRTXNASDAQ:NTLA
Read CRISPR Therapeutics sets sights on gene-editing cures for disease
Affirm stock price
December 26, 2023 6:59 AM ET

Affirm Holdings: Time to ring the register?

Jea Yu

Buy-now-pay-later (BNPL) platform provider Affirm Holdings Inc. (NASDAQ: AFRM) stock is up 439% year-to-date (YTD). If you’re wondering if

NASDAQ:AFRMNYSE:SHOPNYSE:SQ
Read Affirm Holdings: Time to ring the register?